CHUGAI PHARMACEUTICAL CO., LTD. Logo

CHUGAI PHARMACEUTICAL CO., LTD.

A research-driven pharmaceutical company developing innovative medical products.

4519 | T

Overview

Corporate Details

ISIN(s):
JP3519400000
LEI:
Country:
Japan
Address:
北区浮間五丁目5番1号

Description

Chugai Pharmaceutical Co., Ltd. is a research and development-driven pharmaceutical company dedicated to creating innovative medical products to address unmet medical needs. As a member of the Roche Group, Chugai leverages its advanced expertise in biotechnology and science to develop novel treatments, establishing a leading position in therapeutic antibodies. The company's strategy emphasizes a shift towards discovery research and early clinical development, the integration of digital technologies, and open innovation through external partnerships. Its core therapeutic areas include oncology, rheumatology, and haemophilia, where it provides biopharmaceuticals and molecular targeted therapies to patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-03-29 09:08
有価証券報告書-第111期(令和3年1月1日-令和3年12月31日)
Japanese 2.4 MB
2021-10-27 08:10
四半期報告書-第111期第3四半期(令和3年7月1日-令和3年9月30日)
Japanese 327.0 KB
2021-07-29 08:08
四半期報告書-第111期第2四半期(令和3年4月1日-令和3年6月30日)
Japanese 335.5 KB
2021-04-27 08:07
四半期報告書-第111期第1四半期(令和3年1月1日-令和3年3月31日)
Japanese 274.6 KB
2021-03-23 08:17
内部統制報告書-第110期(令和2年1月1日-令和2年12月31日)
Japanese 24.9 KB
2021-03-23 08:14
確認書
Japanese 9.6 KB
2021-03-23 08:13
有価証券報告書-第110期(令和2年1月1日-令和2年12月31日)
Japanese 2.4 MB
2020-10-28 08:13
四半期報告書-第110期第3四半期(令和2年7月1日-令和2年9月30日)
Japanese 341.6 KB
2020-07-30 08:06
四半期報告書-第110期第2四半期(令和2年4月1日-令和2年6月30日)
Japanese 345.5 KB
2020-04-28 08:07
四半期報告書-第110期第1四半期(令和2年1月1日-令和2年3月31日)
Japanese 286.4 KB
2020-03-30 08:45
有価証券報告書-第109期(平成31年1月1日-令和1年12月31日)
Japanese 1.7 MB
2019-10-30 07:41
四半期報告書-第109期第3四半期(2019/07/01-2019/09/30)
Japanese 281.1 KB
2019-07-26 08:11
四半期報告書-第109期第2四半期(2019/04/01-2019/06/30)
Japanese 279.3 KB
2019-04-26 08:07
四半期報告書-第109期第1四半期(2019/01/01-2019/03/31)
Japanese 237.0 KB
2019-03-28 07:31
有価証券報告書-第108期(平成30年1月1日-平成30年12月31日)
Japanese 1.5 MB

Automate Your Workflow. Get a real-time feed of all CHUGAI PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CHUGAI PHARMACEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CHUGAI PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.